FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
AARTIDRUGS
401234567896012345678930123456789.9012345678900123456789
+15.25 (+3.40%)
Previous Close: 448.65
1D
5D
1M
3M
1Y
5Y
Popular Posts
See All

Pranjal Singh

Bear News: #TATAMOTORS loss increase 15.4% #JSLHISAR profit decline 14% #AARTIDRUGS profit decline 29% DGCA restrict 50% #SPICEJET flights. #NIFTYAUTO

Kishore kumar Ganta

V Trade Point

*Futures & Options educational trades for the week 16.8.21 to 29.8.21* (My trade guidelines -appended below - apply). #stockmarket OPTIONS #AARTIDRUGS *AARTIIND ce 940* cmp 24.00 buy upto 15.00 stop 9.00 target 41.00/58.00+

Sridhar Balakrishnan

Elliott Wave

#AARTIDRUGS Swingtraders Check aartidrugs and find there is any pattern you can get I guess it's good to go long

Ajmal shamsudeen

Elliott Wave

AnandRathi target on AARTIDRUGS Date: 17-May-21 Broker: AnandRathi Price @ Call: 752 Target: 949 Potential: 26.2% Recommendation: BUY

ReportBot

Trade The Trendy Wave

Elliott Wave

Stocks in the news Sayaji Hotels: Subsidiary Sayaji Hotels Management (SHML) has signed and entered into 7 management agreement for the expansion of SHML by having new properties in Andhra Pradesh, Gujrat, Uttarakhand, Rajasthan and Maharashtra. Aarti Drugs: Subsidiary Aarti Speciality Chemicals stands out to be one of the beneficiaries of the Government of India's recently approved Production Linked Incentive scheme for the pharmaceutical sector. NMDC: The company has fixed prices of iron ore - lump ore (65.5 percent, 6-40mm) at Rs 5,100 per tonne and fines (64 percent, -10mm) at Rs 4,210 per tonne - w.e.f. March 6. PNC Infratech: CARE revised the company's PNC Delhi Industrialinfra's credit rating on long-term bank facilities to A- from BBB+, with stable outlook. Tata Chemicals: ICICI Prudential Mutual Fund lowered its shareholding in the company to 3.05 percent from 3.37 percent via open market transactions. India Grid Trust: The company signed a share purchase agreement to acquire NER-II Transmission, from Sterlite Power as part of the Framework Agreement. The indicative value of the acquisition is around Rs 4,625 crore and would boost IndiGrid's AUM by 34 percent to over around Rs 20,000 crore ($2.8 billion) #AARTIDRUGS #NMDC #TATACHEM

TradeAdda

Axis Direct target on AARTIDRUGS Date: 28-Jan-21 Broker: Axis Direct Price @ Call: 702.55 Target: 812 Potential: 0.16% Recommendation: BUY

ReportBot

Daily Stock Insight

Subscription Status on Day 2 #MazagonDockIPO - 7.52x and #LikhithaInfrastructureIPO-3x #UTIAMCIPO-0.79x One can subscribe Mazgaon & Likhitha👍 My Detailed Analysis: Mazgaon Dock IPO & UTIAMC IPO & Likhitha IPO -Live Analysis | AartiDrugs Bonus Latest News: https://bit.ly/3jhhOnF #InvestmentIdeas #AARTIDRUGS

Jagdish Jha

Finvest Capitals

Finvest Capitals

#AARTIDRUGS Aarti Drugs - Q4 FY20 (Audited –Cons) CMP: 861 Total income from operations at 449.6 Cr 459.1 Cr (-2.11%) YoY | 473.5 Cr (-5.07%) QoQ Year ending revenue: 1,806 Cr Vs. 1,560 Cr (15.71%) Net Profit of 58.8 Cr 27.4 Cr (114.61%) YoY 27.7 Cr (114.92%) QoQ Year ending Net profit: 141.4 Cr Vs. 89.7 Cr (58.43%) EPS (in Rs.) 25.26 12.06 YoY | 11.92 QoQ Year ending EPS: 60.57 Vs. 38.48 View: Result is in line with the expectation. Although topline decreased but bottom line improved significantly in this quarter. Further net profit also includes profit on sale of assets of Rs 8.37 Cr. Business Updates & Highlights: EBITDA in Q4FY20 is around INR 72.1 Cr Vs. 57.1 Cr in Q4FY19 therefore up by 26.3% in YoY. EBITDA in FY20 is around 263.3 Cr Vs. 209.6 Cr in FY19. Operating profit margin is also stable in QoQ. Financial ROE and ROCE is around INR 19% and 28.2% respectively and book value per share is around INR 239 and share is currently trading at 3.6x of its book value. Company is currently trading at annualized PE of around 14.5 which is very fair as per industry benchmark. Promoter holding is around 61.4% in the company which is very good. FIIs and mutual fund hold around 1.07% and 4.19% in the company. Cash and cash equivalent as of March 2020 in operating activities is around INR 250.7 Cr. Liquidity position is slightly better in this quarter but still its high and debtor realization is around 3.5 months. Share View: Share price high 880 (52 week) and now 860. Share is almost doubled in 1.5 months in march 20 share was trading around 480. Aarti Drugs Ltd is one of the leading pharmaceutical manufacturers in India. The company is engaged manufacturing of pharmaceuticals. ADL operates in the anti-diarrhea, anti-inflammatory and anti-biotic therapeutic segments. The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited. Position: Share support price is INR 820/775. Mid/Long term investor should continue with the company with target price of INR 980 Opportunities: The Company is also in the process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved. Company has been able to carve a niche for itself and is looking forward to expand the volumes. Consumer spending on medicines is expected to increase, which will spur growth in the generic sector in the domestic market. Risk: Share price trading at all time high any good correction in near future in the market can correct the share price eg. March when Nifty traded below 8000 and share was trading around 480. Disclaimer: Views are shared based on market research and study and personal in nature. Others can take the different view and opinions. Please do the thoroughly study before enter or exit the shares. RD Stock (“High Returns with Low Risk is the Key”)

Sridhar Balakrishnan

The Wave Perspective

HDoverseasmarket-display-image
Reputation: 751  •  Sep 25 7:21 AM

AARTI DRUGS LTD 1 DAY CHART DOUBLE TOP CHART PATTERN CREATE AVOID BUY
AARTIDRUGS - chart - 12953595
Like
Comment
Share
Add a comment
Wealth Mentors-display-image
Reputation: 802  •  Sep 21 4:47 AM

Buy
Aarti Drug
Cmp: 486
TGT: 490- 510- 530
Sl: 470
Cash
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,588  •  Sep 8 2:01 AM
Ahead of Market: 10 things that will decide D-St action on Friday
Nifty50 made strong gains and closed near the psychological mark of 17,800 level. After a gap-up start, the index ended up forming a small bullish candle with a long lower wick, suggesting intraday selling was bought into. Analysts said a follow-up buying might help gauge the strength of the up move.
The Economic Times
Like
Comment
Share
Add a comment
Kamal Kumar-display-image
Reputation: 0  •  Aug 30 8:51 AM
Like
Comment
Share
Add a comment
Kamal Kumar-display-image
Reputation: 0  •  Aug 30 8:50 AM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,588  •  Aug 28 4:56 AM
Ahead of Market: 10 things that will decide stock action on Monday
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said the short term trend of Nifty is range bound with volatility and the consolidation movement is expected to continue for the next week. “We expect Nifty to trade in a range of 17,800-17,300 levels by next week. Any decisive breakout on either side is likely to accelerate momentum in the market.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,588  •  Aug 19 4:36 AM
Commerce ministry for imposing anti-dumping duty on Chinese ofloxacin medicine
Ofloxacin is used to treat certain infections including bronchitis, pneumonia and infection of skin, bladder, urinary tract and prostate. DGTR had conducted the probe following a complaint from Aarti Drugs Ltd about the dumping and initiation of the investigation. The directorate works under the ministry.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,588  •  Aug 17 2:16 AM
Ahead of Market: 10 things that will decide D-Street action on Thursday
Osho Krishan, Sr Analyst - Technical & Derivative Research, Angel One, said the unilateral movement of the index has placed it towards the psychological mark of 18,000, which might hinder the ongoing up move, followed by the weekly swing high of 18,100-18,150 odd levels that might act as a sturdy wall for the bulls.
The Economic Times
Like
Comment
Share
Add a comment
Pranjal Singh-display-image
Reputation: 3,581  •  Aug 13 6:26 AM

⚠️ AARTIDRUGS making higher highs near support zone. if it sustains above 435 targets of 450-470 can be seen in coming weeks.

#AARTIDRUGS #NIFTYPHARMA #NIFTY50 #InvestmentIdeas #InvestingUniversity
AARTIDRUGS - chart - 11521346
8 Likes
1 Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,588  •  Aug 12 7:41 AM
Balaji Amines arm files DRHP with Sebi for IPO
Balaji Speciality Chemicals manufactures niche chemicals such as ethylene diamine, piperazine anhydrous, diethylenetriamine, aminoethyl ethanolamine and aminoethyl piperazine, using the monoethanol amine process.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,588  •  Jul 29 3:41 AM
Hold Aarti Drugs, target price Rs 435: Axis Securities
Aarti Drugs Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 3757.71 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
Kishore kumar Ganta -display-image
Reputation: 4,502  •  Jul 28 1:23 AM
3 Likes
1 Comment
Share
Add a comment
vijay jaria-display-image
Reputation: 29,316  •  Jul 24 12:03 PM

COMPANY NAME RESULT DATE
#AARTIDRUGS 27 Jul 2022
#ADROITINFO 27 Jul 2022
#ALLSEC 27 Jul 2022
#APCOTEXIND 27 Jul 2022
#APLAPOLLO 27 Jul 2022
#BAJFINANCE 27 Jul 2022
#BANARBEADS 27 Jul 2022
#BIGBLOC 27 Jul 2022
#BIOCON 27 Jul 2022
#BLUEDART 27 Jul 2022
#CGPOWER 27 Jul 2022
#CHEMFAB......read more
Like
Comment
Share
Add a comment
ChartArt TA-display-image
Reputation: 5,466  •  Jun 12 1:40 AM
Like
Comment
Share
Add a comment
V Trade Point-display-image
Reputation: 1,470  •  Apr 4 2:34 AM
1 Like
Comment
Share
Add a comment
Elliott Wave-display-image
Reputation: 14,554  •  Apr 1 5:32 AM
Like
Comment
Share
Add a comment
ResultsBot-display-image
Reputation: 21,715  •  Jan 29 12:30 PM

#AARTIDRUGS will declare results on Jan 31, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Stock Sangreh-display-image
Reputation: 5,048  •  Dec 28, 2021 9:57 AM


Fundamental views :
1. Aarti drugs is the largest manufacturer in the world for metformin under API (active pharmaceutical ingredients) in pharma sector which gives the multifold return to its investor.
2. ROCE and ROE is above 25% from the last 3 years.
3. compa......read more
AARTIDRUGS - 6609202
Like
Comment
Share
Add a comment